MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
MASON, Ohio - AtriCure, Inc. (NASDAQ: ATRC), a company specializing in medical devices for atrial fibrillation (Afib) and related conditions, has recently obtained regulatory approval to market its ...
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results